Novartis AG (NVS)
160.06
+1.86
(+1.18%)
USD |
NYSE |
Feb 11, 16:00
159.66
-0.40
(-0.25%)
Pre-Market: 07:35
Novartis EPS Diluted (Quarterly) : 1.249 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Amgen, Inc. | 2.45 |
| AstraZeneca PLC | 0.743 |
| Gilead Sciences, Inc. | 1.74 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.404B |
| Revenue (Quarterly) | 13.33B |
| Total Expenses (Quarterly) | 10.93B |
| Enterprise Value | 329.62B |
| Gross Profit Margin (Quarterly) | 73.44% |
| Profit Margin (Quarterly) | 18.03% |
| Earnings Yield | 4.49% |
| Operating Earnings Yield | 5.46% |
| Normalized Earnings Yield | 4.721 |